iRhythm: Buy the Structural Shift Toward Profitable Growth
iRhythm's recent selloff over a delayed product launch created a buying opportunity. With 2026 guidance of $870-880M (17-18% growth), positive free cash flow, $1.74B of cash on the balance sheet and an EV/sales multiple in the mid-single digits, the risk/reward favors a long trade sized for a volatility-aware portfolio. This idea lays out an entry,…